Branimir I Sikic

3PUBLICATIONS
9CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Feb 26, 2024
Continuous 72-h infusion of zosuquidar with chemotherapy in patients with newly diagnosed acute myeloid leukemia stratified for leukemic blast P-glycoprotein phenotype.

John F Marcelletti, Branimir I Sikic

|Sep 17, 2023
Carboplatin-induced upregulation of pan β-tubulin and class III β-tubulin is implicated in acquired resistance and cross-resistance of ovarian cancer.

Margareta Pernar Kovač, Vanja Tadić, Juran Kralj

|Aug 21, 2023
A clinical trial of zosuquidar plus gemtuzumab ozogamicin (GO) in relapsed or refractory acute myeloid leukemia (RR AML): evidence of efficacy based on leukemic blast P-glycoprotein functional phenotype.

John F Marcelletti, Branimir I Sikic

Pageof 1

Frequent Collaborators

2 joint publications

John F Marcelletti

1 joint publications

Margareta Pernar Kovač

1 joint publications

Vanja Tadić

1 joint publications

Juran Kralj